A Bayesian approach to Weibull survival models -- application to a cancer clinical trial
DOI10.1007/BF00128573zbMath0862.62079OpenAlexW2079736115WikidataQ52314688 ScholiaQ52314688MaRDI QIDQ1125992
Doug Errington, Deborah Ashby, Keith Abrams
Publication date: 3 June 1997
Published in: Lifetime Data Analysis (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1007/bf00128573
exponential distributionWeibull distributionsurvival timesclinical trialasymptotic approximationsLaplace approximationsconstant hazard rationeutron therapyparametric proportional hazards modelspelvic tumourstime varying hazard rates
Applications of statistics to biology and medical sciences; meta analysis (62P10) Bayesian inference (62F15)
Related Items (1)
Uses Software
Cites Work
- Statistical decision theory and Bayesian analysis. 2nd ed
- Combining probability distributions: A critique and an annotated bibliography
- A Bayesian approach to Weibull survival models -- application to a cancer clinical trial
- Bayesian forecasting and dynamic models
- The Intrinsic Bayes Factor for Model Selection and Prediction
- Splines in Statistics
- Bayesian residual analysis in the presence of censoring
- Applications of a Method for the Efficient Computation of Posterior Distributions
- Accurate Approximations for Posterior Moments and Marginal Densities
- Approximate Bayesian analysis of censored survival data
- Bayesian Methods in Practice: Experiences in the Pharmaceutical Industry
- The Fitting of Exponential, Weibull and Extreme Value Distributions to Complex Censored Survival Data Using GLIM
- Fully Exponential Laplace Approximations to Expectations and Variances of Nonpositive Functions
- Bayesian Approaches to Randomized Trials
- Dynamic Bayesian Models for Survival Data
- Bayes Factors
- A Generalization of the Gamma Distribution
- Saddlepoint Approximations in Statistics
- Unnamed Item
- Unnamed Item
- Unnamed Item
- Unnamed Item
- Unnamed Item
- Unnamed Item
- Unnamed Item
- Unnamed Item
This page was built for publication: A Bayesian approach to Weibull survival models -- application to a cancer clinical trial
